Booster Immunization Study of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)
Clinical trial NCT05050474 · COMPLETED
Trial details
- NCT number
- NCT05050474
- Sponsor
- Livzon Pharmaceutical Group Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-07
- Primary completion
- 2022-02-18
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.